Benjamin F. Edwards & Company’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | $13.4M | Buy |
42,959
+5,377
| +14% | +$1.58M | 0.24% | 117 |
|
|
2024
Q1 | $10.7M | Buy |
37,582
+2,160
| +6% | +$632K | 0.19% | 134 |
|
|
2023
Q4 | $10.2M | Buy |
35,422
+4,440
| +14% | +$1.21M | 0.2% | 129 |
|
|
2023
Q3 | $8.33M | Buy |
30,982
+1,256
| +4% | +$313K | 0.32% | 75 |
|
|
2023
Q2 | $6.6M | Buy |
29,726
+6,750
| +29% | +$1.57M | 0.25% | 87 |
|
|
2023
Q1 | $5.55M | Buy |
22,976
+1,140
| +5% | +$280K | 0.23% | 96 |
|
|
2022
Q4 | $5.74M | Buy |
21,836
+1,173
| +6% | +$314K | 0.26% | 94 |
|
|
2022
Q3 | $4.66M | Sell |
20,663
-592
| -3% | -$143K | 0.23% | 101 |
|
|
2022
Q2 | $5.17M | Buy |
21,255
+339
| +2% | +$83.1K | 0.25% | 93 |
|
|
2022
Q1 | $5.06M | Buy |
20,916
+3,111
| +17% | +$715K | 0.23% | 103 |
|
|
2021
Q4 | $4.01M | Buy |
17,805
+316
| +2% | +$66.7K | 0.18% | 125 |
|
|
2021
Q3 | $3.72M | Buy |
17,489
+694
| +4% | +$160K | 0.19% | 124 |
|
|
2021
Q2 | $4.09M | Sell |
16,795
-862
| -5% | -$212K | 0.21% | 113 |
|
|
2021
Q1 | $4.39M | Sell |
17,657
-277
| -2% | -$66.1K | 0.24% | 103 |
|
|
2020
Q4 | $4.12M | Sell |
17,934
-1,726
| -9% | -$398K | 0.24% | 103 |
|
|
2020
Q3 | $5M | Sell |
19,660
-389
| -2% | -$96.4K | 0.34% | 69 |
|
|
2020
Q2 | $4.73M | Sell |
20,049
-2,308
| -10% | -$527K | 0.34% | 70 |
|
|
2020
Q1 | $4.53M | Buy |
22,357
+148
| +0.7% | +$32.3K | 0.39% | 65 |
|
|
2019
Q4 | $5.35M | Buy |
22,209
+143
| +0.6% | +$31.5K | 0.38% | 65 |
|
|
2019
Q3 | $4.27M | Buy |
22,066
+854
| +4% | +$164K | 0.33% | 70 |
|
|
2019
Q2 | $3.91M | Buy |
21,212
+1,363
| +7% | +$244K | 0.33% | 75 |
|
|
2019
Q1 | $3.77M | Buy |
19,849
+1,840
| +10% | +$351K | 0.34% | 69 |
|
|
2018
Q4 | $3.51M | Buy |
18,009
+1,264
| +8% | +$247K | 0.36% | 65 |
|
|
2018
Q3 | $3.47M | Sell |
16,745
-2,696
| -14% | -$531K | 0.33% | 72 |
|
|
2018
Q2 | $3.59M | Sell |
19,441
-638
| -3% | -$113K | 0.35% | 66 |
|
|
2018
Q1 | $3.42M | Sell |
20,079
-63
| -0.3% | -$11.6K | 0.35% | 66 |
|
|
2017
Q4 | $3.5M | Buy |
20,142
+4,360
| +28% | +$772K | 0.37% | 67 |
|
|
2017
Q3 | $2.94M | Buy |
15,782
+1,633
| +12% | +$289K | 0.35% | 73 |
|
|
2017
Q2 | $2.44M | Buy |
14,149
+2,551
| +22% | +$415K | 0.32% | 82 |
|
|
2017
Q1 | $1.9M | Buy |
11,598
+457
| +4% | +$75.9K | 0.28% | 85 |
|
|
2016
Q4 | $1.63M | Buy |
11,141
+2,641
| +31% | +$397K | 0.27% | 91 |
|
|
2016
Q3 | $1.42M | Buy |
8,500
+780
| +10% | +$132K | 0.25% | 94 |
|
|
2016
Q2 | $1.18M | Buy |
7,720
+1,400
| +22% | +$218K | 0.23% | 99 |
|
|
2016
Q1 | $947K | Buy |
6,320
+1,003
| +19% | +$149K | 0.2% | 115 |
|
|
2015
Q4 | $863K | Sell |
5,317
-56
| -1% | -$8.8K | 0.19% | 124 |
|
|
2015
Q3 | $743K | Buy |
5,373
+845
| +19% | +$133K | 0.16% | 136 |
|
|
2015
Q2 | $695K | Buy |
4,528
+161
| +4% | +$25.8K | 0.14% | 158 |
|
|
2015
Q1 | $698K | Sell |
4,367
-131
| -3% | -$20.6K | 0.15% | 149 |
|
|
2014
Q4 | $716K | Buy |
4,498
+304
| +7% | +$47.4K | 0.17% | 140 |
|
|
2014
Q3 | $589K | Buy |
4,194
+1,970
| +89% | +$257K | 0.15% | 156 |
|
|
2014
Q2 | $263K | Buy |
2,224
+6
| +0.3% | +$695 | 0.07% | 261 |
|
|
2014
Q1 | $274K | Buy |
2,218
+905
| +69% | +$110K | 0.08% | 234 |
|
|
2013
Q4 | $150K | Buy |
1,313
+34
| +3% | +$3.87K | 0.05% | 281 |
|
|
2013
Q3 | $143K | Buy |
1,279
+4
| +0.3% | +$434 | 0.05% | 263 |
|
|
2013
Q2 | $126K | Buy |
+1,275
| New | +$132K | 0.05% | 259 |
|
Other funds holding AMGN
Benjamin F. Edwards & Company's AMGN Position: Q2 2024 in Review
Benjamin F. Edwards & Company increased its Amgen (AMGN) stake by 14% in Q2 2024, buying an estimated $1.58M and bringing the position to 42,959 shares worth $13.4M. The position accounts for 0.24% of the portfolio, ranked #117.
Benjamin F. Edwards & Company first reported a position in AMGN in Q2 2013 and has held it in 45 quarters since. 2,785 funds tracked by Wall St. Rank hold AMGN as of Q2 2024.
- Benjamin F. Edwards & Company held 42,959 shares of Amgen worth $13.4M as of Q2 2024.
- Benjamin F. Edwards & Company bought 5,377 Amgen shares in Q2 2024, an estimated $1.58M.
- Amgen made up 0.24% of Benjamin F. Edwards & Company's portfolio in Q2 2024, its #117 holding.
- Benjamin F. Edwards & Company first reported a position in Amgen in Q2 2013 and has held it in 45 quarters since.
- 2,785 funds tracked by Wall St. Rank held Amgen as of Q2 2024.
Based on Benjamin F. Edwards & Company's 13F filing for Q2 2024, filed 12 Aug 2024.